Dr. Arpana Sharma

About

Dr. Arpana Sharma is an ICMR-Research Associate in the Department of Pathology and Cancer Screening at Chittaranjan National Cancer Institute, Ministry of Health & Family Welfare, Government of India. She holds a Ph.D. in Life Sciences from Central University of Gujarat (2020), with research experience in cancer biology, molecular biology and cell biology. Her expertise includes cell culture, flow cytometry, microscopy, protein and molecular biology techniques, bioinformatics, and clinical data analysis. Her research interests focus on cancer biology, molecular mechanisms of cancer, and translational cancer research.

Experience

• 8 years of research experience

Qualification

• Ph.D. (LifeSciences)
• M.Sc (Biotechnology); M.Sc (Botany)

Award & Recognition

• Awarded first prize in Cancer Awareness Programme organized by NSS, Mewar University, Rajasthan (2022).
• Awarded second prize in poster presentation at Gujarat Science Congress 2020, organized by Ganpat University.
• Qualified Gujarat State Eligibility Test (G-SET) for Assistant Professor in Life Science, accredited by UGC, New Delhi (2019).
• Awarded first prize in oral presentation at the National Seminar on Immunological Advances in Health Management: Current Scenario & Future Perspectives, Central University of Gujarat (2017).
• Qualified CSIR-UGC JRF examination with All India Rank 13, sponsored by CSIR, New Delhi.
• 3 additional awards/recognitions

Research

• Sharma A., Kartha A., Singh R.P. and Mishra J.P.N. (2018) "Efficiency of Anti-Epileptic Drug Topiramate in Treatment of Glioblastoma: An In Vitro Perception." Scholars Bulletin, 4(5): 440-449.
• Sharma A., Mishra J.P. and Singh R.P. (2019) "Effect of Flavonoids on Cell Viability and Glutamate-Induced Migration of U87MG Glioma Cells." International Journal of Pharmacy and Biological Sciences, 9(1): 1208-1216.
• Sharma A., Mishra J.P., Dhaked G.S., Jhanwar R. and Jain N. (2021) "In-Vitro Anti-Cancer Efficiency of Silibinin Against U7MG Glioblastoma Cells." Journal of Indian Research, 9(3-4): 32-38.
• Sharma A., Srivastava Y., Prasad S., Ghosh S., Kumar R.S., Bharti A.C., Singh R.P. and Nasare V.D. (2026) "SLC7A11 as a molecular nexus of prognosis, resistance, and therapeutic roadmap in cancer: A systematic review and meta-analysis." International Journal of Biological Macromolecules, 335: 149257.
• Ghosh S., Sharma A., Kumar R.S. and Nasare V. (2025) "Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeutics." Medical Oncology, 42(1): 29.
• Chaki R., Basak S., Sharma A., Nasare V.D., Ghosh N. and Mandal S.C. (2025) "Biocompatible Nanocarriers of Bioactive Flavonoid Naringin: Design, Formulation, and Comprehensive Characterization." Journal of Applied Pharmaceutical Science, 15(08): 117-126.

OTHER PUBLICATIONS/REVIEWS

• 3 additional publications/reviews.
• 4 book chapters.

Certifications

• Completed CRISPR Basic Certification Course, Biotecnika & Rasayanika.
• Completed Flow Cytometry Technique Master Certification Course, Biotecnika & Rasayanika.
• Successfully completed Advance Program in Clinical Research and Management, CLINI INDIA.
• 4 additional workshops/training/symposium participations.

Area of Interest

• Cancer Biology, Molecular Biology, Cell Biology, Translational Cancer Research